Browse the evidence

Activation of the PI3K-mTOR signaling pathway by insulin, amino acids, and resistance exercise is the central mechanism regulating skeletal muscle protein synthesis and hypertrophy.

To maximize muscle growth, you must combine resistance exercise with adequate protein intake. The body uses a common signaling pathway (mTOR) to integrate these signals. Simply taking protein supplements or exercising without nutrition is less effective than doing both together, as they synergistically activate the pathway responsible for building muscle.

Treatment with 0.6 mg/day of the long-acting GLP-1 derivative liraglutide for 8 weeks significantly improves glycemic control (reducing fasting glucose and HbA1c) in obese patients with type 2 diabetes without causing weight gain.

If you have type 2 diabetes and are obese, taking 0.6 mg of liraglutide once daily for at least 8 weeks will significantly lower your fasting blood sugar and HbA1c. However, do not expect to lose weight or change your energy expenditure in this timeframe; your weight will likely stay the same. This treatment is effective for blood sugar control without the weight gain often seen with other diabetes drugs.

Liraglutide improves beta-cell function (HOMA-S) in patients with type 2 diabetes, as indicated by a significant increase in HOMA-S compared to placebo.

This treatment helps your pancreas work better at producing insulin in response to blood sugar levels, which is a key factor in managing type 2 diabetes.

Females and males experience similar relative increases in muscle hypertrophy and lower-body strength when following the same resistance training protocol, but females exhibit a significantly larger relative increase in upper-body strength.

If you are a female starting resistance training, do not expect your absolute strength numbers to match males, but expect your relative improvements in upper-body strength to be greater than males. For muscle size and lower-body strength, your relative progress will be on par with males. Stick to the same training protocols used by males; you do not need a different program to see excellent results.

Accumulating sleep debt (4 hours time-in-bed over 5 days) diminishes functional connectivity between the amygdala and the ventral anterior cingulate cortex (vACC), which downregulates the amygdala's functional suppression and enhances its response to negative emotional stimuli (fear), leading to increased anxiety and mood deterioration.

Consistently restricting your sleep to around 4 hours a night for several days will likely increase your anxiety and emotional reactivity to stress. This happens because your brain's ability to regulate fear responses (specifically the connection between the amygdala and the anterior cingulate cortex) is weakened. To maintain emotional stability, prioritize getting adequate sleep (around 8 hours) rather than just managing sleepiness.

Objective actigraphy reveals significantly lower physical activity and dampened circadian rhythms in individuals with current depressive or anxiety disorders compared to controls, whereas self-reported measures fail to capture these objective differences.

For individuals with depression or anxiety, relying on memory or self-reports of activity and sleep is often inaccurate. Objective monitoring via actigraphy reveals that these individuals are significantly less active and have more disrupted circadian rhythms than healthy controls. This objective data is crucial for accurate assessment and monitoring treatment response, as self-reports may miss these critical disturbances.

Elevated body iron stores, indicated by higher serum ferritin levels, are associated with a significantly increased risk of developing type 2 diabetes.

If you have high ferritin levels, it may indicate an increased risk for type 2 diabetes. This is likely due to oxidative stress damaging insulin-producing cells. You should discuss your ferritin levels with a doctor to determine if phlebotomy or dietary adjustments are appropriate, rather than self-prescribing iron restriction.

Higher dietary intake of heme-iron is associated with an increased risk of developing type 2 diabetes.

High intake of heme-iron (found in red meat) is linked to a higher risk of type 2 diabetes. Consider diversifying your protein sources to include more plant-based or poultry options to manage your heme-iron intake, especially if you have other risk factors for diabetes.

Hunter-gatherer populations exhibit very low prevalence of obesity and metabolic diseases (such as type 2 diabetes and hypertension) despite high physical activity levels, suggesting that lifestyle factors beyond simple energy balance (e.g., diet composition, pathogen load) are critical for metabolic health.

Adopting a lifestyle with high physical activity and whole-food diets can significantly reduce the risk of obesity, diabetes, and hypertension, even into old age. Focus on maintaining muscle mass and activity levels rather than fearing these diseases as inevitable.

In postmenopausal women with a normal body mass index (BMI 18.5–24.9), higher levels of body fat (specifically whole-body and trunk fat) are associated with a significantly elevated risk of invasive breast cancer, particularly estrogen receptor-positive (ER+) subtypes.

If you are a postmenopausal woman with a normal BMI, your body fat percentage still matters for breast cancer risk. High body fat, especially around the trunk, is linked to a significantly higher risk of ER-positive breast cancer, even if your weight is healthy. Focus on maintaining healthy body fat levels through diet and exercise, rather than just focusing on BMI.

A short dietary screener (Multifactor Screener) using frequency questions and regression-based scoring algorithms can estimate usual intake of fruits, vegetables, percentage energy from fat, and fiber with correlations (0.5–0.8) comparable to full Food Frequency Questionnaires (FFQs), while exhibiting lower attenuation of relative risk estimates.

For large-scale health surveys or epidemiological studies, using a validated short dietary screener (like the Multifactor Screener) is a viable and efficient alternative to lengthy Food Frequency Questionnaires. It provides comparable accuracy in estimating fruit, vegetable, fat, and fiber intake while reducing respondent burden and minimizing the attenuation of observed health risks.

Lifestyle modification and metformin treatment can modulate gut microbiota and maintain glucose homeostasis in type 2 diabetes, suggesting similar potential for post-GDM women.

For post-GDM women, lifestyle changes and metformin have been shown to help manage blood sugar and potentially improve gut bacteria. However, adherence to lifestyle changes is often poor after delivery, and metformin's use as a preventive strategy is still debated. Prioritize sustainable lifestyle habits.

A literacy-sensitive, culturally tailored diabetes self-management intervention significantly improves glycemic control (HbA1c) and dietary quality in low-income Latino patients with type 2 diabetes over a 4-month period, though these glycemic benefits are not sustained at 12 months without ongoing support.

For low-income Latino patients with type 2 diabetes, a structured, culturally relevant program focusing on diabetes knowledge, self-efficacy, and hands-on skills (like cooking and glucose monitoring) can significantly improve blood sugar control and diet quality within 4 months. However, without ongoing support, these benefits tend to fade after a year. To maintain results, patients need strategies to sustain behavioral changes, such as regular follow-ups or booster sessions, rather than relying solely on an initial intensive course.

Daily Heart Rate Variability (HRV) metrics, when averaged weekly, reveal parasympathetic hyperactivity (increased RMSSD and HF power) in endurance athletes experiencing functional overreaching (F-OR), whereas isolated single-day measurements fail to detect these autonomic changes.

If you are an endurance athlete suspecting overtraining, do not rely on a single daily HRV reading. Instead, record your Heart Rate Variability (specifically RMSSD) every morning upon waking. Calculate the weekly average of these values. A rising trend in your weekly average RMSSD during a heavy training block, accompanied by a drop in performance, is a strong indicator of parasympathetic hyperactivity and functional overreaching, signaling that you need a recovery taper.

Testosterone replacement therapy (TRT) restores serum testosterone to normal ranges, thereby improving mood, energy, sexual function, lean body mass, erythropoiesis, and bone mineral density in hypogonadal men.

If you have clinically low testosterone and symptoms like low energy, low libido, or loss of muscle mass, TRT can restore your levels to normal and improve these symptoms. There are many forms of treatment (gels, patches, injections, buccal tablets) to suit your preference. Regular monitoring of your prostate and blood counts is essential to ensure safety.

Testosterone replacement therapy improves bone mineral density (BMD) and reduces fracture risk in hypogonadal men, with effects mediated by both androgen and estrogen receptors.

If you have low testosterone, you are at higher risk for osteoporosis and fractures. TRT can help build and maintain bone density, bringing it back to normal levels. This is a key benefit beyond just sexual health and muscle mass.

Zinc is an essential micronutrient required for over 300 enzymes and 1000 transcription factors, playing critical roles in protein synthesis, DNA synthesis, immune function, and insulin stability.

Ensure adequate dietary zinc intake, prioritizing animal sources like oysters, meat, and dairy for better bioavailability. If you have conditions affecting absorption (like malabsorption syndromes) or are in a high-risk demographic (pregnant women, elderly), consider monitoring levels or supplementing, as zinc is critical for immune function and enzyme activity.

Excessive zinc intake inhibits the absorption of copper and iron, potentially leading to copper deficiency and anaemia, respectively.

If you are supplementing with zinc, be aware that high doses can block copper and iron absorption. Monitor your levels and consider balancing your intake or spacing out supplements if taking high doses long-term.

Randomized trials in children aged six months to twelve years showed that zinc supplementation reduces all-cause and infectious disease mortality and has a minor positive impact on linear growth.

For children in high-risk or deficient regions, zinc supplementation is a critical intervention to reduce mortality and support growth.

Multi-component non-pharmacological sleep therapy (including cognitive behavioral therapy, sleep restriction, bright-light therapy, and body temperature manipulation) reverses the neurocognitive vigilance deficits associated with chronic primary insomnia, normalizing reaction time profiles to match healthy controls.

If you suffer from chronic insomnia, cognitive behavioral sleep therapy combined with sleep restriction, bright light exposure, and body temperature manipulation can reverse the brain fog and vigilance deficits associated with the condition. This multi-component approach, delivered over 6 weeks, normalizes cognitive performance to levels seen in healthy sleepers, suggesting that insomnia-related cognitive issues are treatable and not permanent.

Untreated sleep-disordered breathing (SDB), particularly obstructive sleep apnea (OSA), is an independent risk factor for incident stroke and recurrent vascular events, with risk increasing with apnea-hypopnea index (AHI).

If you snore loudly or feel excessively sleepy during the day, get tested for sleep apnea. Treating it with CPAP or other therapies can significantly lower your risk of having a stroke or having another one if you've already had one. It is not just 'bad breathing'; it is a direct threat to your cardiovascular health.

Semaglutide (1.0 mg once-weekly) significantly improves fasting and postprandial glucose and lipid metabolism in subjects with obesity, primarily through delayed first-hour gastric emptying and GLP-1 receptor agonism.

For individuals with obesity, semaglutide (1.0 mg weekly) significantly improves how the body handles glucose and fats after eating. This is achieved by slowing down the initial emptying of the stomach, which prevents rapid spikes in blood sugar and lipids. This benefit occurs even in people without diabetes, suggesting it may be a valuable tool for metabolic health in obesity.

Elevated levels of branched-chain amino acids (BCAAs) and aromatic amino acids, along with altered lipid profiles (e.g., elevated palmitic acid), serve as consistent metabolomic signatures of obesity and insulin resistance.

If you have obesity, check your metabolic markers, specifically amino acids and fatty acids. Elevated BCAAs and certain fatty acids like palmitic acid are linked to insulin resistance. Monitoring these can help identify metabolic dysfunction early, even if your weight is stable.

Weight loss interventions, including hypocaloric diets and exercise, modulate the metabolomic profile of obese individuals, potentially reversing or altering obesity-related metabolic signatures.

Weight loss through diet or exercise changes your metabolic profile. This means that losing weight can help reverse some of the metabolic abnormalities associated with obesity, such as insulin resistance and altered amino acid levels.